Q&A: New Preprint Server for Clinical Research

The cofounder of bioRxiv, Richard Sever, discusses why there’s a need for the preprint server medRxiv that launched today.

Written byChia-Yi Hou
| 4 min read
Richard Sever bioRxiv medRxiv preprint server launch

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Today (June 5), Cold Spring Harbor Laboratory, Yale University, and The BMJ are launching medRxiv, a preprint server for clinical research. It joins the likes of bioRxiv for basic biology and arXiv for math and physics, although medRxiv will have more stringent requirements for manuscripts. Authors will be asked to provide competing interests, all relevant ethical guidelines, clinical trial IDs, and other detailed information.

Richard Sever of Cold Spring Harbor Labortory is a cofounder of medRxiv and its predecessor bioRxiv, which was launched in 2013. The Scientist spoke to Sever about the launch of medRxiv.

The Scientist: What is the need for preprint servers?

Richard Sever: In general, there are a number of reasons. I think first and foremost it is speeding up dissemination of research. If you submit a paper to a journal, it takes on average about seven months before the work is actually published. But that’s an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies